Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma

British Journal of Cancer

Volumn 91, Issue 8, 2004, Pages 1495-1499

  Vetter, C S ^a   Lieb, W ^b   Brocker E B ^a   Becker, J C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b St Vincentius Kliniken gAG   (Germany)

Author keywords

Melanoma; MIC A B; NK; NKG2D; Uvea

Indexed keywords

ALPHA INTERFERON; FOTEMUSTINE; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; CD57 ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL ACTIVATING RECEPTORS;

ARTICLE; CELL INFILTRATION; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MINIMUM INHIBITORY CONCENTRATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TUMOR CELL; TUMOR ESCAPE; UVEA MELANOMA; CELLULAR IMMUNITY; ENZYME IMMUNOASSAY; MELANOMA; METABOLISM; PATHOLOGY; SKIN TUMOR; UVEA TUMOR;

ANTIGENS, CD57; DISEASE PROGRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; IMMUNOENZYME TECHNIQUES; LIGANDS; MELANOMA; MEMBRANE PROTEINS; RECEPTORS, IMMUNOLOGIC; SKIN NEOPLASMS; UVEAL NEOPLASMS;

EID: 7944225836     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602123     Document Type: Article

References (36)

1. Albert DM, Niffenegger AS, Willson JK (1992) Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 36: 429-438
2. Algarra I, Cabrera T, Garrido F (2000) The HLA crossroad in tumor immunology. Hum Immunol 61: 65-73
3. Bahram S (2000) MIC genes: from genetics to biology. Adv Immunol 76: 1-60
4. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729
5. Blom DJ, Luyten GP, Mooy C, Kerkvliet S, Zwinderman AH, Jager MJ (1997a) Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest Ophthalmol Vis Sci 38: 1865-1872
6. Blom DJ, Schurmans LR, Waard-Siebinga I, Wolff-Rouendaal D, Keunen JE, Jager MJ (1997b) HLA expression in a primary uveal melanoma, its cell line, and four of its metastases. Br J Ophthalmol 81: 989-993
7. Campoli M, Chang CC, Ferrone S (2002) HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 20(Suppl 4): A40-A45
8. Chin L, Merlino G, DePinho RA (1998) Malignant melanoma: modern black plague and genetic black box. Genes Dev 12: 3467-3481
9. Cohen Y, Goldenberg-Cohen N, Parrella P, Chowers I, Merbs SL, Pe'er J, Sidransky D (2003) Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci 44: 2876-2878
10. Collins RW, Stephens HA, Clare MA, Vaughan RW (2002) High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers. Hum Immunol 63: 783-794
11. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954
12. Edmunds SC, Kelsell DP (2002) Double jeopardy: Ras and CDK4 co-expression in skin cancer. Trends Mol Med 8: 548
13. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA (2002) Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci 43: 2845-2851
14. Ericsson C, Seregard S, Bartolazzi A, Levitskaya E, Ferrone S, Kiessling R, Larsson O (2001) Association of HLA class I and class II antigen expression and mortality in uveal melanoma. Invest Ophthalmol Vis Sci 42: 2153-2156
15. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivela T (1999) Screening for metastatic malignant melanoma of the uvea revisited. Cancer 85: 1151-1159
16. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL (1993) Natural history of HLA expression during tumour development. Immunol Today 14: 491-499
17. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93: 12445-12450
18. Groh V, Bruhl A, El Gabalawy H, Nelson JL, Spies T (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 100: 9452-9457
19. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2: 255-260
20. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T (1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96: 6879-6884
21. Hicklin DJ, Marincola FM, Ferrone S (1999) HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 5: 178-186
22. Hunt C, Morimoto RI (1985) Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci USA 82: 6455-6459
23. Jager MJ, Hurks HM, Levitskaya J, Kiessling R (2002) HLA expression in uveal melanoma: there is no rule without some exception. Hum Immunol 63: 444-451
24. Ksander BR, Chen PW (1999) Immunotherapy of uveal melanoma. Dev Ophthalmol 30: 220-230
25. Liu H, Lightfoot R, Stevens JL (1996) Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem 271: 4805-4812
26. Lo ML, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, Procaccini M, Ferrari F, De Rosa G, Altieri DC (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89: 2244-2248
27. Ma D, Luyten GP, Luider TM, Niederkorn JY (1995) Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 36: 435-441
28. Ma D, Niederkorn JY (1995) Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology 86: 263-269
29. Naus NC, Zuidervaart W, Rayman N, Slater R, van Drunen E, Ksander B, Luyten GP, Klein A (2000) Mutation analysis of the PTEN gene in uveal melanoma cell lines. Int J Cancer 87: 151-153
30. Rothenfusser S, Buchwald A, Kock S, Ferrone S, Fisch P (2002) Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes. Cell Immunol 215: 32-44
31. Seliger B, Abken H, Ferrone S (2003) HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 24: 82-87
32. Soufir N, Bressac-de Paillerets B, Desjardins L, Levy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D (2000) Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer 82: 818-822
33. Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T (2001) Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53: 279-287
34. Stephens HA (2001) MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 22: 378-385
35. Vetter CS, Groh V, Thor SP, Spies T, Brocker EB, Becker JC (2002) Expression of stress-induced MHC class I related chain molecules on human melanoma. J Invest Dermatol 118: 600-605
36. Woll E, Bedikian A, Legha SS (1999) Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 9: 575-581